​

Moleculin Biotech Ownership | Who Owns Moleculin Biotech?

OverviewForecastFinancialsChartTranscripts

Moleculin Biotech Ownership Summary

Moleculin Biotech is owned by 17.39% institutional investors, and 82.61% retail investors. Vanguard US Total Market Shares ETF is the top mutual fund, with 0.97% of its assets in Moleculin Biotech shares.

MBRX Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockMoleculin Biotech17.39%-82.61%
SectorHealthcare Stocks 57.39%9.93%32.68%
IndustryBiotech Stocks 68.48%9.65%21.87%

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 20232315.00%5,183,666140.87%1733.10%10100.00%4-
Sep 30, 202320-9.09%2,152,050-5.84%711.47%5-28.57%4-20.00%
Jun 30, 202322-4.35%2,285,496-24.48%77.17%7-36.36%566.67%
Mar 31, 202323-4.17%3,026,4391.15%109.62%11-8.33%3-40.00%
Dec 31, 20222414.29%2,992,1640.26%109.63%1250.00%566.67%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard US Total Market Shares ETF40.47K0.97%-13.02K
Vanguard Total Stock Mkt Idx Inv16.86K0.56%-23.61K
Vanguard Institutional Extnd Mkt Idx Tr30.31K0.23%-
Fidelity Extended Market Index14.36K0.11%-
Northern Trust Extended Eq Market Idx1.74K0.05%-
NT Ext Equity Mkt Idx Fd - NL1.74K0.04%-
NT Ext Equity Mkt Idx Fd - L1.74K0.04%-
NT Ext Equity Mkt Idx Fd - DC - NL - T21.36K0.03%-25.00
SSgA U.S. Extended Market Index Class I11.70K0.03%-
Spartan Total Market Index Pool G1.12K0.03%-

Insider Transactions Trends

DateBuySell
2024 Q4--
2024 Q3--
2024 Q2--
2023 Q43-
2023 Q3--

MBRX Ownership FAQ

Who Owns Moleculin Biotech?

Moleculin Biotech shareholders are primarily institutional investors at 17.39%, followed by 0% insiders and 0% retail investors. The average institutional ownership in Moleculin Biotech's industry, Biotech Stocks , is 68.48%, which Moleculin Biotech falls below.

Does Blackrock own Moleculin Biotech?

BlackRock is not among the top 10 institutional shareholders of Moleculin Biotech.

Who is the top mutual fund holder of Moleculin Biotech shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Moleculin Biotech shares, with 0.97% of its total shares outstanding invested in 40.47K Moleculin Biotech shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools